News

Author By Vaderis Therapeutics AGPosted on 21/08/202221/08/2022

Vaderis Therapeutics AG announces Clinical Proof-of-Concept Trial in HHT

Vaderis is a biotechnology company focusing on treatment of rare and Orphan Diseases caused by Vascular Malformations
Read More

Vaderis Therapeutics AG
WSJ-350 3.05,
Lichtstrasse 35,
4056 Basel,
Switzerland
+41 79 592 20 05
info@vaderis.com

HOME
MEDICAL NEED
LEADERSHIP TEAM
SCIENTIFIC ADVISORY BOARD
INVESTMENTS & PARTNERSHIPS
PIPELINE
NEWS
CONTACT VADERIS

Privacy

© Vaderis 2023